For the quarter ending 2026-03-31, INBP has $26,669K in assets. $7,687K in debts. $5,826K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 5,826 | 5,314 | 4,732 | 3,615 |
| Accounts receivable, net | 3,655 | 3,592 | 3,983 | 5,430 |
| Inventories | 8,119 | 8,363 | 10,469 | 9,362 |
| Other current assets | 374 | 550 | 440 | 356 |
| Total current assets | 17,974 | 17,819 | 19,624 | 18,763 |
| Property and equipment, net | 1,697 | 1,765 | 1,819 | 1,723 |
| Operating lease right-of-use assets | 3,204 | 366 | 612 | 855 |
| Finance lease right-of-use assets | 151 | 157 | 164 | 171 |
| Deferred tax assets, net | 3,591 | 3,388 | 3,269 | 3,337 |
| Security deposits and other assets | 52 | 52 | 52 | 52 |
| Total assets | 26,669 | 23,547 | 25,540 | 24,901 |
| Accounts payable | 2,965 | 2,144 | 2,800 | 2,267 |
| Accrued expenses and other current liabilities | 1,376 | 1,130 | 1,490 | 1,302 |
| Current portion of finance lease obligations | 47 | 46 | 45 | 45 |
| Operating lease, liability, current | 1,139 | 221 | 429 | 634 |
| Total current liabilities | 5,527 | 3,541 | 4,764 | 4,248 |
| Finance lease obligations | 80 | 92 | 104 | 115 |
| Operating lease obligations | 2,080 | 145 | 183 | 221 |
| Total liabilities | 7,687 | 3,778 | 5,051 | 4,584 |
| Common stock, 0.002 par value 50,000,000 shares authorized 31,094,510 and 31,059,610 shares issued and outstanding, respectively | 62 | 61 | 62 | 62 |
| Additional paid-in capital | 51,914 | 51,864 | 51,822 | 51,773 |
| Accumulated deficit | -32,895 | -32,058 | -31,296 | -31,419 |
| Less treasury stock, at cost, 34,900 shares | 99 | 99 | 99 | 99 |
| Total stockholders' equity | 18,982 | 19,769 | 20,489 | 20,317 |
| Total liabilities and stockholders' equity | 26,669 | 23,547 | 25,540 | 24,901 |
INTEGRATED BIOPHARMA INC (INBP)
INTEGRATED BIOPHARMA INC (INBP)